Live
- IND vs AUS Boxing Day Test 2024: Sam Konstas Debuts, Travis Head’s Fitness in Question
- Congress Challenges Election Rule Amendments In Supreme Court
- Jaishankar’s US Visit: Key Diplomatic Engagement Amid Leadership Transition
- Orthodox Church Bishop Criticizes PM Modi’s Christmas Celebration Participation
- Janhvi style & grace takes centre stage
- Allu Arjun’s Pushpa 2 Becomes First Hindi-Dubbed Film to Cross Rs 700 Crore
- ‘Legally Veer’ pre-release event creates buzz
- ‘Chinni’ from ‘Daaku Maharaaj’ that strikes a chord with audience
- A raw and intense love story ‘Premikudu’ set to captivate audiences
- Apple iPhone 15 Now Available for Rs 26,999 on Flipkart – Grab the Deal Today!
Dr Reddy's launches heartburn capsules in US market
Drug firm Dr Reddy's Laboratories on Monday said it has launched over-the-counter Lansoprazole capsules used for treatment of frequent heartburn in the US market.
Hyderabad: Drug firm Dr Reddy's Laboratories on Monday said it has launched over-the-counter Lansoprazole capsules used for treatment of frequent heartburn in the US market.
The company has launched Lansoprazole delayed-release capsules USP in the strength of 15 mg in the US market, as approved by the United States Food and Drug Administration (USFDA), Dr Reddy's said in a BSE filing.
"We are pleased to continue to expand our antacids and PPI portfolio for our customers," Dr Reddy's Laboratories Senior Vice President and Head of US OTC and Specialty Rx Divisions Milan Kalawadia said.
The company's product is over-the-counter store-brand equivalent to Takeda Pharmaceuticals North America Inc's Prevacid 24HR capsules, the company said.
